| Literature DB >> 32258078 |
Xu Feng1, Jia-Sheng Cao1, Ming-Yu Chen1, Bin Zhang1, Sarun Juengpanich1, Jia-Hao Hu1, Win Topatana1, Shi-Jie Li1, Ji-Liang Shen1, Guang-Yuan Xiao2, Xiu-Jun Cai1, Hong Yu3.
Abstract
BACKGROUND: There is a controversy as to whether laparoscopic surgery leads to a poor prognosis compared to the open approach for early gallbladder carcinoma (GBC). We hypothesized that the laparoscopic approach is an alternative for early GBC. AIM: To identify and evaluate the safety and feasibility of laparoscopic surgery in the treatment of early GBC.Entities:
Keywords: Early gallbladder carcinoma; Laparoscopic surgery; Meta-analysis; Open surgery; Survival
Year: 2020 PMID: 32258078 PMCID: PMC7103978 DOI: 10.12998/wjcc.v8.i6.1074
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Figure 1A preferred reporting items for systematic reviews and meta-analyses diagram detailing the search strategy and identification of studies for the systematic review and meta-analysis.
Characteristics of the included comparative studies
| Jang et al[ | 2019 | South Korea | Laparoscopic surgery | Retro | 2004-2017 | No | 7 |
| Feng et al[ | 2019 | China | Retro | 2008-2017 | No | 7 | |
| Jang et al[ | 2016 | South Korea | Retro | 2000-2014 | Yes | 7 | |
| Itano et al[ | 2015 | Japan | Retro | 2007-2013 | No | 7 | |
| Agarwal et al[ | 2015 | India | Retro | 2011-2013 | No | 7 | |
| Ha et al[ | 2014 | South Korea | Retro | 1996-2009 | No | 6 | |
| Goetze et al[ | 2013 | Germany | Retro | NA | No | 7 |
Retro: Retrospective study; NA: Not available.
Detailed information including T stage of tumor, survival rate, and recurrence in the included comparative studies
| Jang et al[ | 2019 | South Korea | Laparoscopic | (55) | T2 | 5-yr OS | 73.1% | 0.116 | 5-yr DFS | 78.0% | 0.017 |
| Open | (44) | 65.7% | 62.4% | ||||||||
| Feng et al[ | 2019 | China | Laparoscopic | (41) | Tis-T3 | 1/3/5-yr OS | 97.1%/69.4%/51.9% | 0.453 | Postoperative incisional metastasis | 4.9% | NA |
| Open | (61) | 94.7%/64.9%/55.7% | 3.3% | ||||||||
| Laparoscopic | (9) | Tis | 5-yr OS | 100.0% | NA | NA | NA | NA | |||
| Open | (4) | NA | NA | ||||||||
| Laparoscopic | (8) | T1b | 5-yr OS | NA | 0.763 | NA | NA | NA | |||
| Open | (9) | 87.5% | NA | ||||||||
| Laparoscopic | (14) | T2 | 5-yr OS | 48.1% | 0.513 | NA | NA | NA | |||
| Open | (32) | 64.7% | NA | ||||||||
| Laparoscopic | (8) | T3 | 5-yr OS | 12.5% | 0.513 | NA | NA | NA | |||
| Open | (16) | 16.0% | NA | ||||||||
| Jang et al[ | 2016 | South Korea | Laparoscopic | (61) | T1 | 5-yr OS | 92.7% | 0.332 | Recurrence | 0.0% | 0.496 |
| Open | (61) | 100.0% | 3.3% | ||||||||
| Itano et al[ | 2015 | Japan | Laparoscopic | (16) | T2 | 3-yr OS | 100.0% | NA | 3-yr recurrence | 0.0% | NA |
| Open | (14) | 71.4% | 28.6% | ||||||||
| Agarwal et al[ | 2015 | India | Laparoscopic | (24) | T1-T3 | NA | NA | NA | 18 mo (6–34 mo) | 4.2% | NA |
| Open | (46) | 6.5% | |||||||||
| Ha et al[ | 2014 | South Korea | Laparoscopic | (25) | T1b/T2 | 1/3/5-yr OS | 94.7%/64.0%/64.0% | 0.607 | NA | NA | NA |
| Open | (150) | 95%/83.4%/76.0% | NA | ||||||||
| Laparoscopic | (15) | T1b | 1/3/5-yr OS | 91.7%/68.8%/68.8% | 0.649 | NA | NA | NA | |||
| Open | (75) | 100.0%/87.6%/ 84.4% | NA | ||||||||
| Laparoscopic | (10) | T2 | 1/3/5-yr OS | 100.0%/50.0%/50.0% | 0.895 | NA | NA | NA | |||
| Open | (75) | 90.0%/79.3%/67.6% | NA | ||||||||
| Goetze et al[ | 2013 | Germany | Laparoscopic | (492) | T1-T4 | 5-yr OS | 37.0% | < 0.05 | Overall recurrence | 54.9% | > 0.05 |
| Open | (200) | 25.0% | 54.5% | ||||||||
| Laparoscopic | (95) | T1 | 5-yr OS | 52.0% | > 0.05 | NA | NA | NA | |||
| Open | (34) | 57.0% | NA | ||||||||
| Laparoscopic | (282) | T2 | 5-yr OS | 33.0% | 0.002 | NA | NA | NA | |||
| Open | (81) | 25.0% | NA | ||||||||
| Laparoscopic | (81) | T3 | 5-yr OS | 24.0% | 0.001 | NA | NA | NA | |||
| Open | (59) | 6.0% | NA | ||||||||
OS: Overall survival; DFS: Disease-free survival; NA: Not available.
P < 0.05.
Figure 2Forest plot and meta-analysis of primary outcome. A: Forest plot and meta-analysis of 1-year overall survival; B: Forest plot and meta-analysis of 3-year overall survival; C: Forest plot and meta-analysis of 5-year overall survival.
Figure 3Forest plot of meta-analysis of secondary outcomes. A: Forest plot of weighted mean difference (WMD) of operation time; B: Forest plot of WMD of intraoperative blood loss; C: Forest plot of WMD of the number of lymph node dissected; D: Forest plot of WMD of postoperative hospital stay; E: Forest plot of odds ratio of postoperative complications. WMD: Weighted mean difference.